TNFSF14 is positively correlated with GSDMB in KIRC (rho = 0.459, p < 0.0001), SKCM (rho = 0.307, p < 0.0001), and ovarian serous cystadenocarcinoma (OV) (rho = 0.251, p < 0.0001) patients (Figures 4C, D). Here, GSDMB is linked to ovarian serous cystadenocarcinoma.